P3 HEALTH PARTNERS INC - PIII STOCK NEWS

P3 Health Partners Inc. (NASDAQ: PIII) announced that it has received a Compliance Letter from the Nasdaq Hearing Panel on October 24, 2022, confirming that the company has cured its filing delinquency. This ensures P3 remains compliant with all applicable listing standards and allows its securities to continue trading on Nasdaq. The letter follows the company's filing of its Annual Report for the fiscal year ended December 31, 2021, and two Quarterly Reports, thereby making P3 current in its filing obligations with the U.S. Securities and Exchange Commission.

P3 Health Partners, Inc. (NASDAQ: PIII) reported a strong revenue growth of 84% in the first half of 2022, totaling $543 million. The at-risk Medicare Advantage membership surpassed 100,000 members. However, net loss increased significantly due to a $851.5 million goodwill impairment, raising PMPM net loss to $1,580. Adjusted EBITDA loss PMPM improved to $78.

The company raised its full-year 2022 revenue guidance to between $1.025 billion and $1.075 billion, driven by membership growth and partnerships.

P3 Health Partners (NASDAQ: PIII) announced the resignation of Chief Financial Officer Eric Atkins, effective November 1, 2022, to pursue a family-related business opportunity in Denver. CEO Sherif Abdou acknowledged Atkins' contributions, noting the doubling of patients served during his tenure. Erin Darakjian, the current Senior VP and Chief Accounting Officer, will serve as interim CFO. The Board of Directors is actively searching for a permanent CFO. Darakjian expressed commitment to continuing the company's mission of patient-centered healthcare amidst this transition.

P3 Health Partners, Inc. (NASDAQ: PIII) announced it will release financial results for the six months ended June 30, 2022, on October 20, 2022, at 4:30 PM ET. A conference call will follow, providing a corporate and financial update. The call will be accessible via toll-free and international lines, and it will be webcast live on the company's Investor page. P3 Health Partners is focused on population health management, enhancing care through a vast network of over 2,600 primary care providers across five states.

P3 Health Partners Inc. (NASDAQ: PIII) announced it received a Staff Delisting Determination from Nasdaq on September 28, 2022, due to non-compliance with financial reporting rules. The determination does not immediately affect trading. The company plans to appeal this ruling and aims to file delinquent reports by October 17, 2022, to regain compliance. The company has faced delays in filing its Annual Report and Quarterly Reports, which were due by September 27, 2022. A hearing request must be made by October 5, 2022, to stay any suspension action.

P3 Health Partners Inc. (NASDAQ: PIII) will have its CEO, Dr. Sherif Abdou, participate in the virtual panel named "Next Frontier – Value Based Care for Sub-Capitation/Specialties" at the Nephron 2nd Annual Physician Enablement Symposium on September 22 at 9:00 am EDT. P3 is a physician-led population health management company that supports over 2,500 primary care providers across five states, focusing on enhancing patient care and reducing costs through value-based care coordination.

P3 Health Partners Inc. (NASDAQ: PIII) has acquired the practice of Dr. Leonardo Serfino in Sierra Vista, Arizona. Dr. Serfino, an internal medicine specialist, will continue to care for his existing patients while accepting new Medicare Advantage patients. This acquisition expands P3 Arizona's network, which includes over 1,400 affiliated primary care providers in multiple counties. David Yarger, Arizona market president, emphasized that this partnership aligns with P3's focus on transforming healthcare to a value-based model that enhances patient outcomes and reduces costs.

P3 Health Partners Inc. (NASDAQ: PIII) announced the appointment of Allen Pate as president of P3 Health Partners-Nevada. Pate will oversee the P3 Nevada Medical Group, ensuring quality care for 20,000 Medicare Advantage patients in Clark and Nye Counties. His extensive healthcare management experience will aid in enhancing patient outcomes through a value-based care model. P3 remains dedicated to improving healthcare experiences while maintaining a network of over 400 primary care affiliate providers.

P3 Health Partners Inc. (NASDAQ: PIII) has expanded its operations in Nye County, Nevada, by acquiring Pahrump Cardiology & Family Practice (PCFP). This addition allows P3 to enhance healthcare access for patients in Pahrump, providing multi-specialty services on-site and eliminating the need for transport to Las Vegas. The acquisition adds approximately 375 patients to P3's platform, broadening its service reach across Nevada. PCFP boasts 12 providers and strengthens P3's network of over 400 primary care providers, supporting around 20,000 patients in the region.